Tissue Sample Collection Instructions
Overview document on how Signatera collections a FFPE sample.
Read Flipbook
Overview document on how Signatera collections a FFPE sample.
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Form necessary to request Signatera tests for use with patients.
Read Flipbook
Prospera™ is a donor-derived cell-free DNA (dd-cfDNA) test for assessment of rejection in post-renal-transplant patients.
Read Flipbook
Detect residual disease and recurrence early in colorectal cancer (CRC). How often should Signatera be ordered for CRC patients?
Read Flipbook
The first personalized ctDNA test to identify molecular residual disease and optimize treatment decisions. Read our billing guide for information about understanding Natera's genetic testing bill.
Read Flipbook
Signatera is a new custom-built test that uses tumor and blood samples to detect very low levels of molecular residual disease (MRD), or small traces of cancer.
Read Flipbook
Overview document detailing blood draw and testing frequency.
Read Flipbook
Altera offers a whole exome and transcriptome-based approach for Comprehensive Genomic Profiling (CGP) with boosted >500X coverage for 440 medically important genes.
Read Flipbook